Grants & Contracts Awards

Size: px
Start display at page:

Download "Grants & Contracts Awards"

Transcription

1 Grants & Contracts Awards Processed by Grants & Contracts Join us as we congratulate the investigators listed below who have recently received a new or competitive renewal award: *Total award amount reflects Direct Costs only for the duration of the project January 2011 Principal Investigator: Kwangwook Ahn, PhD Department/Program: Molecular Pharmacology & Chemistry Project Title: T32 Training Grant with Cornell Total Award* Amount: $48,975 Award Date: 01/25/11 Awarding Agency: Weill Medical College of Cornell University/National Institutes of Health Principal Investigator: Boris C. Bastian, MD, PhD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: THE GNAQ Pathway as a Therapeutic Target in Uveal Melanoma Total Award* Amount: $1,143,965 Award Date: 01/06/11 Project Duration: 4 Years Awarding Agency: National Cancer Institute/ National Institutes of Health Principal Investigator: Milan Chheda, MD Department/Program: Neurology Service Project Title: Characterization of GEFT as a Novel Glioblastoma Oncogene Total Award* Amount: $739,826 Award Date: 01/26/11 Awarding Agency: National Institute of Neurological Disorders and Stroke/ National Institute on Drug Abuse Principal Investigator: Gabriela Chiosis, PhD Department/Program: Medicine/Breast Cancer Medicine/Molecular Pharmacology & Chemistry Project Title: PU-H71 Cistrome to Identify New Cobminatorial Targets in SLBCL Total Award* Amount: $1,000 Award Date: 01/07/11 Awarding Agency: Clinical and Translational Science Center/ Weill Medical College of Cornell University Principal Investigator: Joseph Deasy, PhD Department/Program: Medical Physics Project Title: Normal Tissue Complication Modeling for Radiotherapy

2 Total Award* Amount: $39,430 Award Date: 01/26/11 Project Duration: 10 Months Awarding Agency: National Cancer Institute/ National Institutes of Health Principal Investigator: James J. Hsieh, MD, PhD Department/Program: Medicine/Genitourinary Oncology Service Project Title: Molecular Mechanism of Checkpoint Control in Leukemia Total Award* Amount: $200,000 Award Date: 01/28/11 Awarding Agency: American Cancer Society Principal Investigator: Danwei Huangfu, PhD Department/Program: Developmental Biology Project Title: 2011 Louis V. Gerstner Young Investigators Fund Award Total Award* Amount: $225,000 Award Date: 01/19/11 Awarding Agency: Louis V. Gerstner Young Investigators Fund Principal Investigator: Mary Goll, PhD Department/Program: Developmental Biology Project Title: 2011 Louis V. Gerstner Young Investigators Fund Award Total Award* Amount: $225,000 Award Date: 01/19/11 Awarding Agency: Louis V. Gerstner Young Investigators Fund Principal Investigator: Jan Grimm, MD, PhD Department/Program: Radiology/Nuclear Medicine Service Project Title: 2011 Louis V. Gerstner Young Investigators Fund Award Total Award* Amount: $225,000 Award Date: 01/19/11 Awarding Agency: Louis V. Gerstner Young Investigators Fund Principal Investigator: Richard N. Kolesnick, MD Department/Program: Medicine/Endocrinology/Molecular Pharmacology & Chemistry Project Title: An Anti-Ceramide Antibody Mitigates the Radiation GI Syndrome Total Award* Amount: $74,994 Award Date: 01/14/11 Awarding Agency: Duke University/ Radiation Countermeasures Center of Research Excellence Principal Investigator: Katharina Kreymborg, PhD Department/Program: Immunology

3 Project Title: Functional Characterization of the New B7 Family Members B7-H3 and B7x and Determining Their Role in Tumor-Immunology Total Award* Amount: $141,000 Award Date: 01/13/11 Awarding Agency: Cancer Research Institute Principal Investigator: Alexander M. Lesokhin, MD Department/Program: Medicine/Lymphoma Service Project Title: Targeting Myeloid Derived Suppressor Cells in Immunotherapy for Melanoma Total Award* Amount: $675,000 Award Date: 01/01/11 Project Duration: 4 Years Awarding Agency: American Cancer Society Principal Investigator: Minkui Luo, PhD Department/Program: Molecular Pharmacology & Chemistry Project Title: Profile Substrates and Inhibitors of Protein Lysine Methyltransferase Total Award* Amount: $751,485 Award Date: 01/21/11 Project Duration: 4 Years Awarding Agency: National Cancer Institute/ National Institutes of Health Principal Investigator: Michael H. Overholtzer, PhD Department/Program: Cell Biology Project Title: 2011 Louis V. Gerstner Young Investigators Fund Award Total Award* Amount: $225,000 Award Date: 01/19/11 Awarding Agency: Louis V. Gerstner Young Investigators Fund Principal Investigator: Marilyn D. Resh, PhD Department/Program: Cell Biology Project Title: Identification of Hedgehog Palmitoylation Inhibitors to Block Pancreatic Cancer Cell Growth Total Award* Amount: $160,000 Award Date: 01/11/11 Project Duration: 3 Year Awarding Agency: Cycle for Survival Principal Investigator: Dirk Remus, PhD Department/Program: Molecular Biology Project Title: 2011 Louis V. Gerstner Young Investigators Fund Award Total Award* Amount: $225,000 Award Date: 01/19/11 Awarding Agency: Louis V. Gerstner Young Investigators Fund

4 Principal Investigator: David Scheinberg, MD, PhD Department/Program: Medicine/Leukemia/Molecular Pharmacology & Chemistry Project Title: Biology of Alpha Particle Immunotherapy Total Award* Amount: $728,279 Award Date: 01/06/11 Awarding Agency: National Cancer Institute/ National Institutes of Health Principal Investigator: Barbara Tanos-Lora, PhD Department/Program: Cell Biology Project Title: Mechanism Controlling Centrosome Duplication Total Award* Amount: $133,859 Award Date: 01/07/11 Awarding Agency: National Institute of General Medical Sciences/National Institutes of Health Principal Investigator: Megan van Overbeek, PhD Department/Program: Molecular Biology Project Title: The Role of Chromatin Architecture in Programmed Double-Strand Breaks Total Award* Amount: $105,964 Award Date: 01/13/11 Awarding Agency: National Institute of General Medical Sciences/National Institutes of Health Principal Investigator: Jedd D. Wolchok, MD, PhD Department/Program: Medicine/Melanoma and Sarcoma Service Project Title: Modulating Anti-Tumor Immunity with Dendritic Cells Total Award* Amount: $34,698 Award Date: 01/06/11 Awarding Agency: New York University School of Medicine/ Melanoma Research Alliance Foundation February 2011 Principal Investigator: Arnab Ghosh, MD, PhD Department/Program: Immunology Project Title: Neovascularuization in GVHD and Growth of Tumors in Recipients of allo-bmt Total Award* Amount: $90,000 Award Date: 10/25/10 Awarding Agency: American Association for Cancer Research Principal Investigator: Amy Lowery, PhD Department/Program: Psychiatry & Behavioral Sciences Project Title: A Survey of Older Pain Patients - Are They a Source of Diversion?

5 Total Award* Amount: $15,000 Award Date: 02/18/11 Awarding Agency: Weill Medical College of Cornell University/National Institute on Aging Principal Investigator: Li-Fan Lu, PhD Department/Program: Immunology Project Title: Function of micrornas in Controlling Regulatory T Cell Biology Total Award* Amount: $87,266 Award Date: 02/17/11 Awarding Agency: National Institute of Allergy and Infectious Diseases/ National Institutes of Health Principal Investigator: Ariela Noy, MD Department/Program: Medicine/Lymphoma Service Project Title: AIDS Malignancy Clinical Trials Consortium Total Award* Amount: $114,117 Award Date: 02/02/11 Awarding Agency: Emmes Corporation/National Institutes of Health Principal Investigator: Li-Xuan Qin, PhD Department/Program: Epidemiology & Biostatistics Project Title: Statistical Methods for Normalizing Microarrays in Cancer Biomarker Studies Total Award* Amount: $989,790 Award Date: 02/18/11 Project Duration: 4 Years Principal Investigator: Marilyn D. Resh, PhD Department/Program: Cell Biology Project Title: Hedgehog Palmitoylation as a Novel Target for Inhibiting Pancreatic Cancer Total Award* Amount: $239,250 Award Date: 02/14/11 Principal Investigator: Chris Sander, PhD Department/Program: Epidemiology & Biostatistics/Biostatistics/Computational Biology Project Title: Resource for Visualization and Analysis of Networks (RAVIN) Total Award* Amount: $100,000 Award Date: 02/18/11 Awarding Agency: University of California, San Diego/National Institutes of Health Principal Investigator: Todd Wenderski, PhD Department/Program: Molecular Pharmacology & Chemistry

6 Project Title: T32 Training Grant with Cornell Total Award* Amount: $45,185 Award Date: 02/01/11 Awarding Agency: Weill Medical College of Cornell University/National Institutes of Health Principal Investigator: Ann Zauber, PhD Department/Program: Epidemiology & Biostatistics Project Title: Phase II Clinical Trial of Celecoxib for Prevention of Sporadic Colorectal Adenomas Total Award* Amount: $165,985 Award Date: 02/01/11 Awarding Agency: Brigham And Women's Hospital/National Cancer Institute March 2011 Principal Investigator: Peter J. Allen, MD, FACS Department/Program: Surgery/Hepatopancreatobiliary Service Project Title: Detection of Pre-Invasive Pancreatic Cysts Using Protein and Glycan Biomarkers Total Award* Amount: $40,500 Award Date: 03/08/11 Awarding Agency: Van Andel Institute/ National Cancer Institute Principal Investigator: Vivek Arora, MD, PhD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: Mechanisms of Prostate Cancer Resistance to Second Generation Anti- Androgens Total Award* Amount: $551,223 Award Date: 03/16/11 Awarding Agency: Congressionally Directed Medical Research Programs/ DOE - Department of Energy Principal Investigator: Robert Benezra, PhD Department/Program: Cancer Biology & Genetics Project Title: The Role of Endothelial Progenitor Cells in Tumor Growth and Metastasis Total Award* Amount: $1,733,746 Award Date: 03/18/11 Awarding Agency: National Cancer Institute/ National Institutes of Health Principal Investigator: Jay O. Boyle, MD Department/Program: Surgery/Head and Neck Service Project Title: Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer

7 Total Award* Amount: $5,000 Award Date: 03/09/11 Awarding Agency: University of Minnesota/American Academy of Otolaryngology-Head and Neck Surgery Fdn Principal Investigator: John Buglino, PhD Department/Program: Immunology Project Title: T32 Training Grant Total Award* Amount: $50,718 Award Date: 03/16/11 Awarding Agency: Weill Medical College of Cornell University/National Institute of Allergy and Infectious Diseases Principal Investigator: Emily H. Cheng, MD, PhD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: Genetic Programs of Non-apoptotic Cell Death Total Award* Amount: $531, Award Date: 03/08/11 Awarding Agency: American Cancer Society Principal Investigator: Gabriela Chiosis, PhD Department/Program: Medicine/Breast Cancer Medicine/Molecular Pharmacology & Chemistry Project Title: Targeting the Heat Shock Response for the Therapy of DLBCL Total Award* Amount: $156,303 Award Date: 03/17/11 Awarding Agency: Weill Medical College of Cornell University/National Institutes of Health Principal Investigator: David J. Chung, MD, PhD Department/Program: Medicine/Bone Marrow Transplant Service Project Title: Evaluation of Immune Responses Mediated by Listeria-Stimulated Human Dendritic Cells: Implications for Cancer Vaccine Therapy Total Award* Amount: $300,000 Award Date: 03/17/11 Awarding Agency: Congressionally Directed Medical Research Programs/ DOD - Department of Defense Principal Investigator: David Cobrinik, MD, PhD Department/Program: Pediatrics/Cheung Research Project Title: Cellular Predisposition to Retinoblastoma Tumorigenesis Total Award* Amount: $1,037,500 Award Date: 03/01/11

8 Principal Investigator: Anna-Katerina Hadjantonakis, PhD Department/Program: Developmental Biology Project Title: Morphogenesis of the Paraxial Mesoderm in Mice Total Award* Amount: $1,303,913 Award Date: 03/29/11 Awarding Agency: National Institute of Child Health and Human Development/National Institutes of Health Principal Investigator: Anna-Katerina Hadjantonakis, PhD Department/Program: Developmental Biology Project Title: Pdgfra Signaling and the Stem Cells of the Early Mammalian Embryo Total Award* Amount: $274,864 Award Date: 03/15/11 Awarding Agency: NYSTEM Program of New York State Department of Health Principal Investigator: Yoon-Chi Han, PhD Department/Program: Cancer Biology & Genetics Project Title: OncmiR-1 in Lymphomagenesis and Hematopoiesis Total Award* Amount: $157,143 Award Date: 03/31/11 Awarding Agency: Leukemia and Lymphoma Society Principal Investigator: Jason T. Huse, MD, PhD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: Personalizing PI3K/AKT Pathway Inhibitor Therapy in Malignant Glioma Total Award* Amount: $100,000 Award Date: 03/14/11 Awarding Agency: American Association for Cancer Research/American Association for Cancer Research Principal Investigator: Gabsang Lee, PhD Department/Program: Developmental Biology Project Title: Disease Modeling of Congenital Insensitivity to Pain and Anhidrosis (CIPA) disease using human ipsc and rescue of its phenotypes Total Award* Amount: $209,360 Award Date: 03/15/11 Awarding Agency: NYSTEM Program of New York State Department of Health Principal Investigator: Christopher D. Lima, PhD Department/Program: Structural Biology

9 Project Title: Targets in M. Tuberculosis: Stress Resistance and Repair Total Award* Amount: $70,000 Award Date: 03/10/11 Awarding Agency: Weill Medical College of Cornell University/National Institute of Allergy and Infectious Diseases Principal Investigator: Sara Olson, PhD Department/Program: Epidemiology & Biostatistics Project Title: Serum IgE and Risk of Pancreatic Cancer Total Award* Amount: $119,599 Award Date: 03/11/11 Principal Investigator: Ouathek Ouerfelli, PhD Department/Program: Organic Synthesis Core Facility (OSCF) Project Title: Biology of Lipoamide Dehydrogenase and 2-Hydroxy-3-Oxoadipate Synthase in Mtb Total Award* Amount: $70,000 Award Date: 03/16/11 Awarding Agency: Weill Medical College of Cornell University/National Institute of Allergy and Infectious Diseases Principal Investigator: Michael H. Overholtzer, PhD Department/Program: Cell Biology Project Title: The Role of Entosis in Human Cancers Total Award* Amount: $1,037,500 Award Date: 03/25/11 Principal Investigator: Mark E. Robson, MD Department/Program: Medicine/Breast Cancer Medicine Service/Clinical Genetics Service Project Title: Preclinical and Brief Exposure Early Clinical Evaluation of an Oral PARP inhibitor for Breast Cancer Prevention in BCRA Mutation Carriers Total Award* Amount: $5,938 Award Date: 03/28/11 Awarding Agency: Dana Farber Cancer Institute/Susan G. Komen Breast Cancer Foundation Principal Investigator: Jennifer Stockdill, PhD Department/Program: Molecular Pharmacology & Chemistry Project Title: C-N Bond-Forming Methodologies for the Synthesis of Small Molecules and Peptides Total Award* Amount: $166,666

10 Award Date: 03/14/11 Awarding Agency: National Institute of General Medical Sciences/National Institutes of Health Principal Investigator: Chambers Stuart, PhD Department/Program: Developmental Biology Project Title: Translational Control of Human Pluripotent Cell Maintenance and Neural Differentiation Total Award* Amount: $230,121 Award Date: 03/15/11 Awarding Agency: NYSTEM Program of New York State Department of Health Principal Investigator: Lorenz Studer, MD Department/Program: Neurosurgery/Departmental/Developmental Biology Project Title: Modeling Pathogenesis and Treatment of Familial Dysautonomia in Patient Specific Human Induced Pluripotent Stem Cells Total Award* Amount: $900,000 Award Date: 03/15/11 Awarding Agency: NYSTEM Program of New York State Department of Health Principal Investigator: Lorenz Studer, MD Department/Program: Neurosurgery/Departmental/Developmental Biology Project Title: Patient-specific human ESCs and IPSCs for Modeling Schwann Cell Differentiation and Charcot-Marie-Tooth Disease Total Award* Amount: $900,000 Award Date: 03/15/11 Awarding Agency: NYSTEM Program of New York State Department of Health Principal Investigator: Richard J. Wong, MD, FACS Department/Program: Surgery/Head and Neck Service Project Title: Mechanisms of Cancer Cell Chemotaxis in Perineural Invasion Total Award* Amount: $1,037,500 Award Date: 03/01/11 April 2011 Principal Investigator: Paula Bos, PhD Department/Program: Immunology Project Title: T Regulatory Cell Function in Breast Cancer Progression and Metastasis Total Award* Amount: $150,000 Award Date: 04/01/11

11 Awarding Agency: American Cancer Society Principal Investigator: Jamie Chaft, MD Department/Program: Thoracic Oncology Service Project Title: Molecular Determinants of Acquired Clinical Resistance to Criztinib in Non- Small Cell Lung Cancer Harboring a Translocation or Inversion Event of the ALK Gene Locus Total Award* Amount: $47,619 Award Date: 04/04/11 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator: Elizabeth Comen, MD Department/Program: Medicine Project Title: The Evaluation of the Cytotoxicity of Select Neutrophils in Inhibiting Metastatic Breast Total Award* Amount: $47,500 Award Date: 04/01/11 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator: Sandra D'Angelo, MD Department/Program: Medicine Project Title: Enhancing the Activity of Temozolomide for the Treatment of Stage Small Cell Lung Cancer by Addition of the PARP-1 Inhibitor Veliparib (ABT-888) Total Award* Amount: $47,620 Award Date: 04/01/11 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator: Hakim Djaballah, PhD Department/Program: High-Throughput Drug Screening Facility Project Title: Regulation of HD-ZIPIII Activity by the START Lipid-binding Domain Total Award* Amount: $26,316 Award Date: 04/27/11 Awarding Agency: Cold Spring Harbor Laboratory/National Science Foundation Principal Investigator: Ayca Gucalp, MD Department/Program: Breast Service Project Title: Targeting the Androgen Signaling Pathway for the Treatment of Advanced Breast Cancer Total Award* Amount: $47,612 Award Date: 04/05/11 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology

12 Principal Investigator: Alexia Iasonos, PhD Department/Program: Epidemiology & Biostatistics Project Title: Designs for Phase I Trials of Combinations of Agents Total Award* Amount: $10,619 Award Date: 04/27/11 Awarding Agency: University of Virginia/National Cancer Institute Principal Investigator: Irene Jarchum, PhD Department/Program: Immunology Project Title: Innate Immune Defense During Clostridium Difficile Colitis Total Award* Amount: $50,000 Award Date: 04/11/11 Awarding Agency: Columbia University/Northeast Biodefense Center Principal Investigator: Komal Jhaveri, MD Department/Program: Medicine Project Title: Increasing Efficiency of Drug Development with a Targeted Imaging Strategy: First-in-Human Phase I Trial of PU-H71, a Novel HSP90 Inhibitor with 124I-PU-H71 for the Treatment of Advanced Malignancies Total Award* Amount: $47,500 Award Date: 04/01/11 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator: Eric Lai, PhD Department/Program: Developmental Biology Project Title: Annotation of the Small RNA/microRNA Component Drosophila Genome Total Award* Amount: $1,431,645 Award Date: 04/01/11 Awarding Agency: National Human Genome Research Institute/National Institutes of Health Principal Investigator: Yueming Li, PhD Department/Program: Molecular Pharmacology & Chemistry Project Title: Mechanism and Therapy of AB-42-Specific Gamma-Secretase Total Award* Amount: $2,245,037 Award Date: 04/22/11 Awarding Agency: National Institute of Neurological Disorders and Stroke/National Institutes of Health Principal Investigator: Elizabeth A. Morris, MD, FACR Department/Program: Radiology/Breast Imaging Service Project Title: Developing an Educational Program on Breast Imaging for the Chinese Radiology Society with International Cooperation

13 Total Award* Amount: $34,320 Award Date: 04/12/11 Awarding Agency: Beijing Institute for Cancer Research/Radiological Society of North America Principal Investigator: Patrick Morris, MBBS Department/Program: Breast Cancer Medicine Service Project Title: Association of Smoking, Lung Inflammation and Lung Metastases from Breast Cancer Total Award* Amount: $47,500 Award Date: 04/14/11 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator: Jamie Ostroff, PhD Department/Program: Psychiatry Project Title: Development of a Web-based, 3D Coping Skills Game to Increase Self-Efficacy for Maintaining Smoking Abstinence Total Award* Amount: $37,175 Award Date: 04/28/11 Awarding Agency: Muzzy Lane Software/National Cancer Institute Principal Investigator: Christopher Y. Park, MD, PhD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: Functional Role of micrornas in Hematopoietic Stem Cells in the Myelodysplastic Syndromes Total Award* Amount: $399,000 Award Date: 04/19/11 Awarding Agency: Congressionally Directed Medical Research Programs Principal Investigator: Paul Paik, MD Department/Program: Medicine Project Title: Characterization of the Molecular Heterogeneity of EGFR Mutant Lung Adenocarcinoma: Baseline and Post-Treatment Tumor Analysis Total Award* Amount: $47,620 Award Date: 04/01/11 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator: William Polkinghorn, MD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: Defining the Role of AR Signaling in Promoting Prostate Cancer Radioresistance Total Award* Amount: $47,500 Award Date: 04/27/11

14 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator: William P. Tew, MD Department/Program: Medicine/Gynecologic Medical Oncology Service Project Title: Geriatric Assessment and Intervention in Elderly Women with Ovarian Cancer Total Award* Amount: $138,888 Award Date: 04/29/11 Awarding Agency: National Comprehensive Cancer Network Foundation Principal Investigator: Emily S. Tonorezos, MD, MPH Department/Program: Medicine/General Internal Medicine Service Project Title: Diet and Insulin Resistance in Survivors of Childhood Leukemia Total Award* Amount: $300,000 Award Date: 04/01/11 Awarding Agency: American Cancer Society May 2011 Principal Investigator: Chong Chen, PhD Department/Program: Cancer Biology & Genetics Project Title: Identifying Druggable Targets in Acute Myeloid Leukemia Total Award* Amount: $165,000 Award Date: 05/11/11 Awarding Agency: Leukemia and Lymphoma Society Principal Investigator: Nai-Kong Cheung, MD, PhD Department/Program: Pediatrics Project Title: Engineering and Evaluation of Human L-Methionase for Cancer Therapy Total Award* Amount: $260,625 Award Date: 05/06/11 Awarding Agency: University of Texas at Austin/ National Institutes of Health Principal Investigator: Mark A. Dickson, MD Department/Program: Medicine/Melanoma and Sarcoma Service Project Title: A Phase II study of PD in Liposarcoma with CDK4 Amplification Total Award* Amount: $200,000 Award Date: 05/26/11 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator: Cherry L. Estilo, DMD Department/Program: Surgery/Dental Service Project Title: Intervention to Prevent Delayed Diagnosis of Oral Cancer

15 Total Award* Amount: $6, Award Date: 05/13/11 Project Duration: 4 Months Awarding Agency: Creighton University/National Institutes of Health Principal Investigator: Alan L. Ho, MD, PhD Department/Program: Medicine/Head and Neck Oncology Service Project Title: A Randomized Phase II Study of Axitinib versus Placebo for Patients with Progressive, Recurrent and/or Metastatic Adenoid Cystic Carcinoma Total Award* Amount: $285,626 Award Date: 05/03/11 Awarding Agency: National Comprehensive Cancer Network/ Pfizer, Inc. Principal Investigator: Danwei Huangfu, PhD Department/Program: Developmental Biology Project Title: MSKCC Society Special Projects Committee Total Award* Amount: $125,000 Award Date: 05/12/11 Awarding Agency: MSKCC Society/ Memorial Sloan-Kettering Cancer Center Principal Investigator: Isabel Lam Department/Program: Molecular Biology Project Title: Functional Characterization of Rec104 in Meiotic Recombination Total Award* Amount: $83,600 Award Date: 05/12/11 Awarding Agency: National Institute of General Medical Sciences/National Institutes of Health Principal Investigator: Philipp Niethammer, PhD Department/Program: Cell Biology Project Title: MSKCC Society Special Projects Committee Total Award* Amount: $125,000 Award Date: 05/12/11 Project Duration: 7 Months Awarding Agency: MSKCC Society/ Memorial Sloan-Kettering Cancer Center Principal Investigator: Bhuvanesh Singh, MD, PhD, FACS Department/Program: Surgery/Head and Neck Service Project Title: Bacterial Colonization, Inflammation and its Role in Carcinogenesis Total Award* Amount: $10,169 Award Date: 05/25/11 Awarding Agency: New York University/National Institute of Dental and Craniofacial Research

16 Principal Investigator: Robert J. Young, MD Department/Program: Radiology/Neuroradiology Service Project Title: Using Functional MRI and Diffusion Tensor Imaging of the Language Pathway to Optimize Brain Tumor Resection Total Award* Amount: $40,000 Award Date: 05/13/11 Awarding Agency: Radiological Society of North America Principal Investigator: Jamie Zampell, MD Department/Program: Surgery Project Title: Adaptive Immune Responses Regulate the Pathophysiology of Lymphedema Total Award* Amount: $99,698 Award Date: 05/27/11 Awarding Agency: DOD - Department of Defense June 2011 Principal Investigator: Claudia Ayash, MPH Department/Program: Psychiatry & Behavioral Sciences Project Title: AMBER- Arab American Breast Cancer Education and Referral Program Total Award* Amount: $63,557 Award Date: 06/14/11 Awarding Agency: New York University School of Medicine/Susan G. Komen Breast Cancer Foundation Principal Investigator: Robert Benezra, PhD Department/Program: Cancer Biology & Genetics Project Title: Novel Approaches to Target High Grade Ovarian Cancers Total Award* Amount: $698,000 Award Date: 07/22/11 Awarding Agency: Starr Cancer Consortium Principal Investigator: Patrick J. Boland, MD, FRCS(I), FRCS Department/Program: Surgery/Orthopaedic Service Project Title: Sacral Study Group and Sacrectomy Total Award* Amount: $20,000 Award Date: 06/23/11 Awarding Agency: Orthopaedic Research and Education Foundation Principal Investigator: Natalya Chernichenko, MD Department/Program: Surgery Project Title: The Role of Rho Family Proteins in Perineural Invasion by Cancer Cells Total Award* Amount: $36,500

17 Award Date: 07/28/11 Awarding Agency: American Head and Neck Society Principal Investigator: Nai-Kong Cheung, MD, PhD Department/Program: Pediatric Project Title: Phase I Study of Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors Total Award* Amount: $415,000 Award Date: 06/01/11 Awarding Agency: National Institutes of Health Principal Investigator: David J. Chung, MD, PhD Department/Program: Medicine/Bone Marrow Transplant Service Project Title: Evaluation of Immune Responses Mediated by Listeria-Stimulated Human Dendritic Cells: Implications for Cancer Vaccine Therapy Total Award* Amount: $300,000 Award Date: 06/06/11 Awarding Agency: Congressionally Directed Medical Research Programs/DOD - Department of Defense Principal Investigator: Joseph Deasy, PhD Department/Program: Medical Physics Project Title: Management of Breathing Effects in Radiotherapy Planning Total Award* Amount: $48,771 Award Date: 06/16/11 Awarding Agency: Massachusetts General Hospital/National Cancer Institute Principal Investigator: James A. Fagin, MD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: Restoration of Radioiodine (RAI) Responsiveness in RAI-Refractory Thyroid Cancer. Total Award* Amount: $199,999 Award Date: 06/02/11 Awarding Agency: MSKCC Society Principal Investigator: Michael Glickman, MD Department/Program: Medicine/Infectious Disease/Immunology Project Title: An Integrated Host and Pathogen Genetic Strategy to Elucidate the Mechanism of Action of BCG in Therapy of Bladder Cancer Total Award* Amount: $393,806 Award Date: 07/27/11

18 Awarding Agency: Starr Cancer Consortium Principal Investigator: Phillip Iaquinta, PhD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: Validation and Characterization of a Novel Prostate Cancer-Specific Genomic Deletion Associated with TMPRSS2-ERG Translocation Total Award* Amount: $105,646 Award Date: 06/17/11 Awarding Agency: Congressionally Directed Medical Research Programs/DOD - Department of Defense Principal Investigator: Teresa Kim, MD Department/Program: Surgery Project Title: Anti-CTLA-4 Enhances the Effects of Imatinib in Gastrointestinal Stromal Tumor Total Award* Amount: $107,776 Award Date: 07/26/11 Principal Investigator: Moritz F. Kircher, MD, PhD Department/Program: Radiology Project Title: Combined Preoperative MRI/Intraoperative Raman Imaging of Brain Total Award* Amount: $199,809 Award Date: 06/02/11 Awarding Agency: MSKCC Society/Memorial Sloan-Kettering Cancer Center Principal Investigator: David S. Klimstra, MD Department/Program: Pathology/Surgical Pathology Diagnostic Services, Gastrointestinal/Surgical Pathology Diagnostic Services, Thoracic Project Title: Dissecting Hedghog,TGF Beta and DMP Signaling During Pancreatic Tumorigenesis Total Award* Amount: $13,988 Award Date: 06/28/11 Awarding Agency: University of Massachusetts/National Institutes of Health Principal Investigator: Marc Ladanyi, MD Department/Program: Pathology/Diagnostic Molecular Pathology Project Title: Mutant EGF Receptor-Dependent Lung Cancer in Human Cell Lines and Transgenic Mice Total Award* Amount: $50,000 Award Date: 06/01/11

19 Awarding Agency: Yale University/National Cancer Institute Principal Investigator: Eirini Papapetrou, MD, PhD Department/Program: Molecular Pharmacology & Chemistry Project Title: Genetic Correction of Human Beta-Thalassemic Induced Pluripotent Stem Cells Total Award* Amount: $166,666 Award Date: 06/24/11 Awarding Agency: National Institute of Diabetes & Digestive & Kidney Diseases/National Institutes of Health Principal Investigator: Christopher Y. Park, MD, PhD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: MSK Society Grant Application Total Award* Amount: $200,000 Award Date: 06/02/11 Awarding Agency: MSKCC Society Principal Investigator: Jae Park, MD Department/Program: Medicine Project Title: Consolidative Adoptive Immunotherapy of B-Cell Leukemia With Genetically Modified Autologous T Cells Total Award* Amount: $47,500 Award Date: 06/21/11 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator: Vladimir Ponomarev, MD, PhD Department/Program: Radiology Project Title: Imaging T-cell Activation and Co-stimulation in Prostate Cancer Immunotherapy Total Award* Amount: $1,037,500 Award Date: 06/01/11 Awarding Agency: National Institutes of Health Principal Investigator: Chris Sander, PhD Department/Program: Epidemiology & Biostatistics/Biostatistics/Computational Biology Project Title: Transforming Genomics Data Visualization for Cancer Research Total Award* Amount: $144,000 Award Date: 06/01/11 Awarding Agency: Starr Cancer Consortium Principal Investigator: Joseph Sun, PhD Department/Program: Immunology

20 Project Title: Natural Killer Cell Responses Against Cancer and Infectious Disease Total Award* Amount: $200,000 Award Date: 06/23/11 Project Duration: 4 Years Awarding Agency: Cancer Research Institute Principal Investigator: Craig B. Thompson, MD Department/Program: Cancer Biology & Genetics Project Title: Apoptosis Control by Bcl-2 Family Members Total Award* Amount: $379,404 Award Date: 06/08/11 Principal Investigator: Craig B. Thompson, MD Department/Program: Cancer Biology & Genetics Project Title: Cancer Cell Survival During Factor Deprivation Total Award* Amount: $582,609 Award Date: 06/21/11 Principal Investigator: Marcel Van Den Brink, MD, PhD Department/Program: Medicine/Division of Hematologic Oncology/Immunology Project Title: Strategies to enhance immune reconstitution after bone marrow transplant Total Award* Amount: $1,680,937 Award Date: 06/10/11 Awarding Agency: National Heart, Lung, and Blood Institute/National Institutes of Health July 2011 Principal Investigator: Carol A. Aghajanian, MD Department/Program: Medicine/Gynecologic Medical Oncology Project Title: A Comprehensive Molecular Profiling and Novel Targeted Therapeutic Intervention for Low-Grade Serous and Serous Borderline Ovarian Cancer Total Award* Amount: $236,854 Award Date: 07/19/11 Awarding Agency: Cycle for Survival/Memorial Sloan-Kettering Cancer Center Principal Investigator: Hikmat A. Al-Ahmadie, MD Department/Program: Pathology/Surgical Pathology Diagnostic Services, Genitourinary Project Title: Genomic Characterization of Small Cell Carcinoma of the Bladder Using Whole Genome Sequencing and Molecular Inversion Probe (MIP) Arrays: a Biomarker Integrated Approach in a Rare but Aggressive Urothelial Neoplasm. Total Award* Amount: $97,902 Award Date: 07/19/11

21 Awarding Agency: Cycle for Survival/Memorial Sloan-Kettering Cancer Center Principal Investigator: Zhirong Bao, PhD Department/Program: Developmental Biology Project Title: The Ubiquitin-Proteasome System in Metazoan Embryogenesis Total Award* Amount: $950,000 Award Date: 07/18/11 Awarding Agency: National Institute of General Medical Sciences/National Institutes of Health Principal Investigator: Michael F. Berger, PhD Department/Program: Pathology/Genetics Research Project Title: High-Throughput Profiling of Genomic Alterations in Clinical Tumor Specimens Total Award* Amount: $400,000 Award Date: 07/18/11 Awarding Agency: Geoffrey Beene Cancer Research Center/Memorial Sloan-Kettering Cancer Center Principal Investigator: Timothy Chan, MD, PhD Department/Program: Radiation Oncology Project Title: Elucidating the Function of the Widely Inactivated Phosphatase PTPRD in the Molecular Pathogenesis of Glioblastoma Total Award* Amount: $1,037,500 Award Date: 07/15/11 Principal Investigator: Sarat Chandarlapaty, MD Department/Program: Medicine/Breast Cancer Medicine Service Project Title: Targeting AKT Inhibitor-Induced Feedback Signaling in Breast Cancer Total Award* Amount: $399,957 Award Date: 07/18/11 Awarding Agency: Geoffrey Beene Cancer Research Center/Memorial Sloan-Kettering Cancer Center Principal Investigator: Ping Chi, MD Department/Program: Medicine Project Title: Elucidating the Roles of ETV1 in the Pathogenesis of GIST Total Award* Amount: $785,135 Award Date: 07/01/11

22 Principal Investigator: Liang Deng, MD, PhD Department/Program: Medicine/Dermatology Service Project Title: Host Defense Against Poxviruses and Viral Immune Evasion Total Award* Amount: $250,000 Award Date: 07/20/11 Awarding Agency: National Institute of Allergy and Infectious Diseases/National Institutes of Health Principal Investigator: Kinh Gian Do, MD, PhD Department/Program: Radiology Project Title: Development of Predictor and Prognostic Markers for Novel Therapies in Pancreatic Neuroendocrine Tumors Total Award* Amount: $148,848 Award Date: 07/19/11 Awarding Agency: Cycle for Survival/Memorial Sloan-Kettering Cancer Center Principal Investigator: Alan L. Ho, MD, PhD Department/Program: Medicine/Head and Neck Oncology Service Project Title: A Phase II Study of MK-2206 in Patients with Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma Total Award* Amount: $239,178 Award Date: 07/19/11 Awarding Agency: Cycle for Survival/Memorial Sloan-Kettering Cancer Center Principal Investigator: Eric Holland, MD Department/Program: Neurosurgery/Departmental/Cancer Biology and Genetics Project Title: Understanding Clonal Evolution and Heterogeneity of the Therapeutic Response by Lineage Tracing in Mouse Models of Glioma Total Award* Amount: $232,264 Award Date: 07/18/11 Awarding Agency: Geoffrey Beene Cancer Research Center/Memorial Sloan-Kettering Cancer Center Principal Investigator: Eric Holland, MD Department/Program: Neurosurgery/Departmental/Cancer Biology and Genetics Project Title: Utilizing Mouse Models of Residual and Recurrent Glioma to Uncover Mechanisms or Therapeutic Resistance Total Award* Amount: $240,000 Award Date: 07/19/11 Awarding Agency: Cycle for Survival/Memorial Sloan-Kettering Cancer Center

23 Principal Investigator: Steven M. Horwitz, MD Department/Program: Medicine/Lymphoma Service Project Title: Novel Target Discovery Through Genomic and Functional Characterization of Mature T-cell Lymphomas Total Award* Amount: $240,000 Award Date: 07/19/11 Awarding Agency: Cycle for Survival/Memorial Sloan-Kettering Cancer Center Principal Investigator: Xuejun Jiang, PhD Department/Program: Cell Biology Project Title: Mechanism and Therapeutic Potential of PTEN Regulation upon Hypoxia Total Award* Amount: $400,000 Award Date: 07/18/11 Awarding Agency: Geoffrey Beene Cancer Research Center/Memorial Sloan-Kettering Cancer Center Principal Investigator: Johanna A. Joyce, PhD Department/Program: Cancer Biology & Genetics Project Title: Developing a Unique Mouse Model of Poorly Differentiated Pancreatic Neuroendocrine Tumors as a Preclinical Trial Platform Total Award* Amount: $240,000 Award Date: 07/19/11 Awarding Agency: Cycle for Survival/Memorial Sloan-Kettering Cancer Center Principal Investigator: Johanna A. Joyce, PhD Department/Program: Cancer Biology & Genetics Project Title: Evaluating CSF1R Inhibition as a Novel Target in Gliomagenesis Total Award* Amount: $240,000 Award Date: 07/19/11 Awarding Agency: Cycle for Survival/Memorial Sloan-Kettering Cancer Center Principal Investigator: Moritz F. Kircher, MD, PhD Department/Program: Radiology Project Title: Combined Pre- and Intraoperative Brain Tumor Imaging Using a Novel Dual- Modality Raman-MRI Nanoparticle Probe Total Award* Amount: $350,466 Award Date: 07/18/11 Awarding Agency: Geoffrey Beene Cancer Research Center/Memorial Sloan-Kettering Cancer Center Principal Investigator: Moritz F. Kircher, MD, PhD Department/Program: Radiology

24 Project Title: Raman Microscope for Label-free Tissue Characterization and High-Sensitivity Detection of Raman Contrast Agents Total Award* Amount: $150,000 Award Date: 07/18/11 Awarding Agency: Geoffrey Beene Cancer Research Center/Memorial Sloan-Kettering Cancer Center Principal Investigator: David W. Kissane, MD Department/Program: Psychiatry and Behavioral Sciences Project Title: Communication Skills Intervention to Promote Transition into Survivorship Total Award* Amount: $2,187,134 Award Date: 07/05/11 Principal Investigator: Robert Klein, PhD Department/Program: Cancer Biology & Genetics Project Title: Transcriptional Regulatory SNPs as a Mechanism for Prostate Cancer Risk Loci Total Award* Amount: $400,000 Award Date: 07/18/11 Awarding Agency: Geoffrey Beene Cancer Research Center/Memorial Sloan-Kettering Cancer Center Principal Investigator: Andrew C. Koff, PhD Department/Program: Molecular Biology Project Title: Exploring the Role of PD on the Treatment of Glioma Total Award* Amount: $150,480 Award Date: 07/19/11 Awarding Agency: Cycle for Survival/Memorial Sloan-Kettering Cancer Center Principal Investigator: Steven M. Larson, MD Department/Program: Radiology/Nuclear Medicine/Molecular Pharmacology & Chemistry Project Title: The ICMIC Bridge Fund Total Award* Amount: $100,000 Award Date: 07/07/11 Awarding Agency: Philanthropic Funds Principal Investigator: Ross Levine, MD Department/Program: Medicine/Human Oncology & Pathogenesis Program (HOPP) Project Title: Whole Genome Sequencing to Identify Germline and Somatic Disease Alleles Total Award* Amount: $69,444 Award Date: 07/07/11 Awarding Agency: Brigham And Women's Hospital/ MPD Foundation

25 Principal Investigator: Jason S. Lewis, PhD Department/Program: Radiology/Radiochemistry Service Project Title: Development of 89Zr-5A10 for the Measurement of AR Signaling in Advanced Prostate Cancer Total Award* Amount: $400,000 Award Date: 07/18/11 Awarding Agency: Geoffrey Beene Cancer Research Center/Memorial Sloan-Kettering Cancer Center Principal Investigator: Paul Paik, MD Department/Program: Medicine Project Title: Squamous Cell Carcinoma of the Lung Mutation Analysis Program (SQ-MAP) Total Award* Amount: $181,630 Award Date: 07/18/11 Awarding Agency: Geoffrey Beene Cancer Research Center/Memorial Sloan-Kettering Cancer Center Principal Investigator: Christopher Y. Park, MD, PhD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: The Role of micrornas in Stem Cells of the Aging Hematopoietic System Total Award* Amount: $91,094 Award Date: 07/06/11 Awarding Agency: American Federation for Aging Research Principal Investigator: John Petrini, PhD Department/Program: Molecular Biology Project Title: Rad50: Roles in Chromosome Stability and Prevention of Malignancy Total Award* Amount: $1,195,047 Award Date: 07/04/11 Project Duration: 4 Years Awarding Agency: National Institute of General Medical Sciences/National Institutes of Health Principal Investigator: Simon N. Powell, MD, PhD, FRCP Department/Program: Radiation Oncology Project Title: Genomic Determinants of Radiosensitivity Total Award* Amount: $400,000 Award Date: 07/18/11 Awarding Agency: Geoffrey Beene Cancer Research Center/Memorial Sloan-Kettering Cancer Center Principal Investigator: Charles Sawyers, MD Department/Program: Human Oncology & Pathogenesis Program (HOPP)

26 Project Title: Translational Research in Oncology Training Program Total Award* Amount: $944,892 Award Date: 07/11/11 Awarding Agency: National Cancer Institute Principal Investigator: David Scheinberg, MD, PhD Department/Program: Medicine/Leukemia/Molecular Pharmacology & Chemistry Project Title: Smart Nano-Devices for Cancer therapy Total Award* Amount: $83,500 Award Date: 07/18/11 Awarding Agency: MSKCC Society Principal Investigator: Ying Taur, MD, MPH Department/Program: Medicine/Infectious Diseases Service Project Title: Effects of the Intestinal Microbiota on Infections During Bone Marrow Transplant Total Award* Amount: $602,375 Award Date: 07/18/11 Awarding Agency: National Institute of Allergy and Infectious Diseases/ National Institutes of Health Principal Investigator: Marcel Van Den Brink, MD, PhD Department/Program: Medicine/Division of Hematologic Oncology/Immunology Project Title: Endothelial Precursor Cells in Allogeneic Bone Marrow Transplantation During Graft-Versus-Host Disease and Graft-Versus-Tumor Activity Total Award* Amount: $400,000 Award Date: 07/18/11 Awarding Agency: Geoffrey Beene Cancer Research Center/Memorial Sloan-Kettering Cancer Center Principal Investigator: Andrea Ventura, MD, PhD Department/Program: Cancer Biology & Genetics Project Title: Investigating the mir-34 Family of Tumor Suppressive mirnas Total Award* Amount: $394,536 Award Date: 07/18/11 Awarding Agency: Geoffrey Beene Cancer Research Center/Memorial Sloan-Kettering Cancer Center Principal Investigator: Andrew J. Vickers, PhD Department/Program: Epidemiology & Biostatistics Project Title: Acupuncture Trialists' Collaboration: Meta-Analysis of Chronic Pain Trials Total Award* Amount: $917,500 Award Date: 07/18/11

27 Awarding Agency: National Center for Complementary and Alternative Medicine Principal Investigator: Jedd D. Wolchok, MD, PhD Department/Program: Medicine/Melanoma and Sarcoma Service Project Title: Summer Research Experiences for Medical Students Supervised by Faculty Mentors Total Award* Amount: $1,283,271 Award Date: 07/29/11 Principal Investigator: Ji Zhang, PhD Department/Program: Cancer Biology & Genetics Project Title: Determining the Mechanism of p53 Resistance in a Mouse Model of B Cell Lymphoma Total Award* Amount: $52,381 Award Date: 07/01/11 Awarding Agency: Leukemia and Lymphoma Society August 2011 Principal Investigator: Luca Cartegni, PhD Department/Program: Molecular Pharmacology & Chemistry Project Title: Activation of Natural RTK Inhibitors in Cancer Therapy Total Award* Amount: $360,000 Award Date: 08/02/11 Awarding Agency: Starr Cancer Consortium Principal Investigator: Sergio Giralt, MD Department/Program: Bone Marrow Transplant Service Project Title: MSKCC BMT CTN PROPOSAL Total Award* Amount: $616,500 Award Date: 08/08/11 Project Duration: 6 Years Awarding Agency: National Heart, Lung, and Blood Institute/National Institutes of Health Principal Investigator: Alan Hall, PhD Department/Program: Cell Biology Project Title: Rho GTPases and Polarity Signaling Pathways in Morphogenesis and Migration Total Award* Amount: $1,524,997 Award Date: 08/15/11 Project Duration: 4 Years Awarding Agency: National Institute of General Medical Sciences/ National Institutes of Health

28 Principal Investigator: James J. Hsieh, MD, PhD Department/Program: Medicine/Genitourinary Oncology Service Project Title: Investigation of the ATRX-Daxx Chromatin-Remodeling Complex in Pancreatic Neuroendocrine Tumors Total Award* Amount: $264,772 Award Date: 08/02/11 Awarding Agency: Starr Cancer Consortium Principal Investigator: Eric Lai, PhD Department/Program: Developmental Biology Project Title: BEN Factors are Conserved CSL Co-Repressors in Notch-Mediated Neural Development Total Award* Amount: $1,207,639 Award Date: 08/26/11 Awarding Agency: National Institute of Neurological Disorders and Stroke/ National Institutes of Health Principal Investigator: Yueming Li, PhD Department/Program: Molecular Pharmacology & Chemistry Project Title: Regulation and Function of Gamma-Secretase Total Award* Amount: $1,025,000 Award Date: 08/17/11 Project Duration: 11 Years Awarding Agency: National Institute on Aging/National Institutes of Health Principal Investigator: Stephen D. Nimer, MD Department/Program: Medicine/Hematology Service/Molecular Pharmacology & Chemistry Project Title: Bromodomain Inhibition as Targeted Therapy in Acute Myeloid Leukemia Total Award* Amount: $333,333 Award Date: 08/15/11 Awarding Agency: Starr Cancer Consortium Principal Investigator: Kenneth Offit, MD Department/Program: Medicine/Clinical Genetics Service/Lymphoma Service Project Title: Genomewide Discovery of Novel Cancer Predisposing Mutations Total Award* Amount: $208,138 Award Date: 08/02/11 Awarding Agency: Starr Cancer Consortium Principal Investigator: Lorenz Studer, MD Department/Program: Neurosurgery/Departmental/Developmental Biology Project Title: Research Training Program in Stem Cell Biology Total Award* Amount: $1,725,000

29 Award Date: 08/05/11 Awarding Agency: NYSTEM Program of New York State Department of Health Principal Investigator: Craig B. Thompson, MD Project Leader: Ariela Noy, M.D. Department/Program: Cancer Biology & Genetics/Lymphoma Service Project Title: Cancer Center Support Grant: AIDS Malignancy Consortium Administrative Supplement Total Award* Amount: $140,294 Award Date: 08/30/11 Principal Investigator: Michel Sadelain, MD, PhD Department/Program: Medicine/Hematology/Molecular Pharmacology & Chemistry Project Title: Regional Immune Interventions to Enhance Mesothelin Targeted Immunotherapy of Malignant Plueral Mesothelioma Total Award* Amount: $1,381,580 Award Date: 08/29/11 Awarding Agency: Congressionally Directed Medical Research Programs Principal Investigator: Charles Sawyers, MD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: Genome Wide Profiling of Single Cells for Diagnosis and Monitoring in Prostate Cancer Total Award* Amount: $120,000 Award Date: 08/02/11 Awarding Agency: Starr Cancer Consortium Principal Investigator: Howard Scher, MD Department/Program: Medicine/Genitourinary Oncology Service Project Title: Genome Wide Profiling of Single Cells for Diagnosis and Monitoring in Prostate Cancer Total Award* Amount: $120,000 Award Date: 08/02/11 Awarding Agency: Starr Cancer Consortium Principal Investigator: Laura H. Tang, MD, PhD Department/Program: Pathology/Surgical Pathology Diagnostic Services, Gastrointestinal Project Title: Investigation of the ATRX-Daxx Chromatin-Remodeling Complex in Pancreatic Neuroendocrine Tumors Total Award* Amount: $89,990 Award Date: 08/02/11

30 Awarding Agency: Starr Cancer Consortium Principal Investigator: Suzanne L. Wolden, MD, FACR Department/Program: Radiation Oncology/Brachytherapy Service/External Beam Radiotherapy Service, Manhattan Project Title: Cardiac Sparing Whole Lung IMRT in Children and Young Adults with Lung Metastases Total Award* Amount: $16,881 Award Date: 08/12/11 Awarding Agency: Northwestern University/National Institutes of Health Principal Investigator: Talia Zaider PhD Department/Program: Psychiatry Project Title: Theraputic Pathways to Improving End of Life Outcomes Among Families in Palliative Care Total Award* Amount: $24,250 Award Date: 08/01/11 Awarding Agency: National Cancer Institute Principal Investigator: Johannes Zakrzewski, MD Department/Program: Immunology Project Title: Strategies to Enhance Thymus-Independent T Cell Development in Cancer Patients Total Award* Amount: $605,045 Award Date: 08/10/11 Principal Investigator: Pat Zanzonico, PhD Department/Program: Molecular Pharmacology & Chemistry Project Title: NanoSPECT/CT for Oncology Research Total Award* Amount: $907,340 Award Date: 08/09/11 Awarding Agency: National Center for Research Resources/National Institutes of Health September 2011 Principal Investigator: Omar Abdel-Wahab, MD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: Role of ASXL1 Mutations in Myeloid Malignancies Total Award* Amount: $786,500 Award Date: 09/20/11

31 Principal Investigator: Tim A. Ahles, PhD Department/Program: Psychiatry/Neuropsychiatry Project Title: The CCNY/MSKCC Partnership for Research Training and Outreach Total Award* Amount: $3,501,011 Award Date: 09/22/11 Principal Investigator: Richard R. Barakat, MD, FACS Department/Program: Surgery/Gynecology Service Project Title: The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and Impact Total Award* Amount: $2,427,007 Award Date: 09/22/11 Awarding Agency: National Institute of Nursing Research/National Institutes of Health Principal Investigator: Ethan M. Basch, MD Department/Program: Medicine Project Title: Development of Pain Endpoint Models for Use in Prostate Cancer Clinical Trials and Drug Approval Total Award* Amount: $439,279 Award Date: 09/15/11 Awarding Agency: Congressionally Directed Medical Research Programs/DOD - Department of Defense Principal Investigator: Emily H. Cheng, MD, PhD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: Apoptotic Network Integrated at the Mitochondrion Total Award* Amount: $184,300 Award Date: 09/08/11 Principal Investigator: Ronald DeMatteo, MD, FACS Department/Program: Surgery/Colorectal Service/Hepatopancreatobiliary Service Project Title: Molecular Mechanisms in Gastrointestinal Stromal Tumor Total Award* Amount: $1,250,000 Award Date: 09/01/11 Project Duration: 13 Years Principal Investigator: Katherine DuHamel, PhD Department/Program: Psychiatry & Behavioral Sciences Project Title: Improving CRC Screening for Diverse Hispanics in an Urban Primary Care Setting

Research and Technology Management

Research and Technology Management Grants & Contracts Awards Processed by Grants & Contracts Join us as we congratulate the investigators listed below who have recently received a new or competitive renewal award (Based on information available

More information

The 2015 donations will be transformative:

The 2015 donations will be transformative: 2015 Impact Funding Allocations Cycle for Survival is determined to beat rare cancers by powering groundbreaking research. Participants and donors fight so all patients have the treatment options they

More information

PRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019

PRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019 MONDAY, JUNE 3, 2019 7:30 AM - 9:15 AM HIGHLIGHTS OF THE DAY 8:00 AM - 9:00 AM S 8:00 AM - 9:15 AM S S 8:00 AM - 11:00 AM S Highlights of the Day Session II Bringing New and Innovative Glioblastoma Treatments

More information

*Total award amount reflects Direct Costs only for the duration of the project

*Total award amount reflects Direct Costs only for the duration of the project Grants & Contracts Awards Join us as we congratulate the investigators listed below who have recently received a new or competitive renewal award: *Total award amount reflects Direct Costs only for the

More information

2008 Oncology Pharmacy Preparatory Review Course Learning Objectives

2008 Oncology Pharmacy Preparatory Review Course Learning Objectives 2008 Oncology Pharmacy Preparatory Review Course Learning Objectives Session 1 Symptom Management, Part I, II & III Teresa A. Mays, Pharm D., BCOP Director, Investigational Drug Department San Antonio,

More information

Summary of Research and Writing Activities in Oncology

Summary of Research and Writing Activities in Oncology Summary of Research and Writing Activities in Oncology Carole Alison Chrvala, PhD 919.545.2149 (Work) 919.951.5230 (Mobile) cchrvala@centurylink.net www.healthmattersmedwriting.com 1 Manuscripts, Posters,

More information

2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives

2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives 2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives Acute Leukemia/Tumor Lysis Syndrome John M. Valgus, Pharm.D., BCOP Hematology/Oncology Specialist University of North

More information

American Cancer Society, Inc. Extramural Grants

American Cancer Society, Inc. Extramural Grants Page: 1 Cancer Control Career Development Award for Primary Care Physicians (CCCDA) CCCDA-14-013-01 Cole, Allison M., MD MENTOR: Baldwin, Laura-Mae, MD, MPH Department of Family Medicine Improving Colorectal

More information

Bihong Zhao, M.D, Ph.D Department of Pathology

Bihong Zhao, M.D, Ph.D Department of Pathology Bihong Zhao, M.D, Ph.D Department of Pathology 04-28-2009 Is tumor self or non-self? How are tumor antigens generated? What are they? How does immune system respond? Introduction Tumor Antigens/Categories

More information

Lecture 1: Carcinogenesis

Lecture 1: Carcinogenesis Lecture 1: Carcinogenesis Anti-cancer (oncology agents): These are perhaps the most dangerous of drugs, other than the narcotic analgesics. This is due to their toxicities. Killing or inhibiting cancer

More information

CLINICAL APPLICATION OF CAR T CELLS

CLINICAL APPLICATION OF CAR T CELLS Memorial Sloan Kettering Cancer Center is pleased to announce CLINICAL APPLICATION OF CAR T CELLS MARCH 10-11, 2016 Conference Location: Memorial Sloan Kettering Cancer Center Zuckerman Research Center

More information

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis. Cancer Biology Chapter 18 Eric J. Hall., Amato Giaccia, Radiobiology for the Radiologist Introduction Tissue homeostasis depends on the regulated cell division and self-elimination (programmed cell death)

More information

September 20, Submitted electronically to: Cc: To Whom It May Concern:

September 20, Submitted electronically to: Cc: To Whom It May Concern: History Study (NOT-HL-12-147), p. 1 September 20, 2012 Re: Request for Information (RFI): Building a National Resource to Study Myelodysplastic Syndromes (MDS) The MDS Cohort Natural History Study (NOT-HL-12-147).

More information

TUMOR M ARKERS MARKERS

TUMOR M ARKERS MARKERS TUMOR MARKERS M.Shekarabi IUMS Definition Many cancers are associated with the abnormal production of some molecules l which h can be measured in plasma. These molecules are known as tumor markers. A good

More information

FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center

FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center 1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699 J. Bennett Johnston Building, Mezzanine (Floor 1A), Suite A102 (504) 988-6060, fax (504) 988-6077,

More information

2017 Internship Directory: Summer Research Experience Program in Oncology- PA Student Applicants (6 pages)

2017 Internship Directory: Summer Research Experience Program in Oncology- PA Student Applicants (6 pages) Dhyan Chandra, PhD Pharmacology and Therapeutics /Dhyan-Chandra Role of Mitochondria in Cancer Prevention and Therapy The main focus of our research is to understand the molecular basis of therapy resistance

More information

Lecture 8 Neoplasia II. Dr. Nabila Hamdi MD, PhD

Lecture 8 Neoplasia II. Dr. Nabila Hamdi MD, PhD Lecture 8 Neoplasia II Dr. Nabila Hamdi MD, PhD ILOs Understand the definition of neoplasia. List the classification of neoplasia. Describe the general characters of benign tumors. Understand the nomenclature

More information

Research and Technology Management

Research and Technology Management Office of Technology Development - Sponsored Research Agreements Join us as we congratulate the Principal Investigators of new industry sponsored research agreements listed below: January 2012 Principal

More information

The Days of Miracles & Wonder... and Science

The Days of Miracles & Wonder... and Science Memorial Sloan Kettering Cancer Center is pleased to announce a one day symposium honoring DR. RICHARD J. O REILLY The Days of Miracles & Wonder... and Science Friday, April 28, 2017 Zuckerman Research

More information

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous Session8 Medical Genetics Cancer Genetics J avad Jamshidi F a s a U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 What is Cancer? Uncontrolled growth of cells Not all tumors

More information

Frontiers in PREVENTION. Research November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA

Frontiers in PREVENTION. Research November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA N I N T H A N N UA L A A C R I N T E R N AT I O N A L CO N F E R E N C E Frontiers in CANCER PREVENTION PROGRAM AND PROCEEDINGS November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA Continuing

More information

Summary of Strategic Competitive Analysis and Publication Planning

Summary of Strategic Competitive Analysis and Publication Planning Summary of Strategic Competitive Analysis and Publication Planning Carole Alison Chrvala, PhD 919.545.2149 (Work) 919.951.5230 (Mobile) cchrvala@centurylink.net www.healthmattersmedwriting.com 1 Briefing

More information

Session 4 Rebecca Poulos

Session 4 Rebecca Poulos The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 20

More information

THE UC SANTA CRUZ GENOMICS INSTITUTE. David Haussler Distinguished Professor, Biomolecular Engineering Scientific Director

THE UC SANTA CRUZ GENOMICS INSTITUTE. David Haussler Distinguished Professor, Biomolecular Engineering Scientific Director THE UC SANTA CRUZ GENOMICS INSTITUTE David Haussler Distinguished Professor, Biomolecular Engineering Scientific Director April 8, 2015 OUR MISSION Unlocking the world s genomic data to accelerate medical

More information

609G: Concepts of Cancer Genetics and Treatments (3 credits)

609G: Concepts of Cancer Genetics and Treatments (3 credits) Master of Chemical and Life Sciences Program College of Computer, Mathematical, and Natural Sciences 609G: Concepts of Cancer Genetics and Treatments (3 credits) Text books: Principles of Cancer Genetics,

More information

Accelerating Translation at Dana-Farber Cancer Institute*

Accelerating Translation at Dana-Farber Cancer Institute* Accelerating Translation at Dana-Farber Cancer Institute* *and our partner institutions February 12, 2013 Edward J Benz JR, MD Dana Farber Cancer Institute 1 2 Academic Structure All Dana-Farber faculty

More information

mirna Dr. S Hosseini-Asl

mirna Dr. S Hosseini-Asl mirna Dr. S Hosseini-Asl 1 2 MicroRNAs (mirnas) are small noncoding RNAs which enhance the cleavage or translational repression of specific mrna with recognition site(s) in the 3 - untranslated region

More information

Cancer. Questions about cancer. What is cancer? What causes unregulated cell growth? What regulates cell growth? What causes DNA damage?

Cancer. Questions about cancer. What is cancer? What causes unregulated cell growth? What regulates cell growth? What causes DNA damage? Questions about cancer What is cancer? Cancer Gil McVean, Department of Statistics, Oxford What causes unregulated cell growth? What regulates cell growth? What causes DNA damage? What are the steps in

More information

Obesity and Risk of Breast Cancer

Obesity and Risk of Breast Cancer Obesity and Risk of Breast Cancer Ayca Gucalp, MD Assistant Attending Memorial Sloan Kettering Cancer Center Instructor of Medicine Weill Cornell Medical College September 5 th, 2014 Case 64 year old postmenopausal

More information

Lecture 1: Carcinogenesis

Lecture 1: Carcinogenesis Lecture 1: Carcinogenesis Anti-cancer (oncology agents): These are perhaps the most dangerous of drugs, other than the narcotic analgesics. This is due to their toxicities. Killing or inhibiting cancer

More information

Session 4 Rebecca Poulos

Session 4 Rebecca Poulos The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 28

More information

BIT 120. Copy of Cancer/HIV Lecture

BIT 120. Copy of Cancer/HIV Lecture BIT 120 Copy of Cancer/HIV Lecture Cancer DEFINITION Any abnormal growth of cells that has malignant potential i.e.. Leukemia Uncontrolled mitosis in WBC Genetic disease caused by an accumulation of mutations

More information

UCI. Anti-Cancer Challenge Impact report. #weareanticancer

UCI. Anti-Cancer Challenge Impact report. #weareanticancer UCI Anti-Cancer Challenge 2017 Impact report #weareanticancer Your support of the UCI Anti-Cancer Challenge is planting the seeds from which UCI research will grow to improve cancer therapies! As Orange

More information

Dr C K Kwan. Associate Consultant, Queen Elizabeth Hospital, HKSAR Honorary member, Targeted Therapy Team, ICR, UK

Dr C K Kwan. Associate Consultant, Queen Elizabeth Hospital, HKSAR Honorary member, Targeted Therapy Team, ICR, UK HA Convention 2013 Dr C K Kwan MBChB, FRCR, FHKCR, FHKAM, MPM, CPI, MAppMgt(Hlth) Associate Consultant, Queen Elizabeth Hospital, HKSAR Honorary member, Targeted Therapy Team, ICR, UK To personalize cancer

More information

TARGETED THERAPY FOR CHILDHOOD CANCERS

TARGETED THERAPY FOR CHILDHOOD CANCERS TARGETED THERAPY FOR CHILDHOOD CANCERS AZIZA SHAD, MD AMEY DISTINGUISHED PROFESSOR OF PEDIATRIC HEMATOLOGY ONCOLOGY, BLOOD AND MARROW TRANSPLANTATION LOMBARDI CANCER CENTER GEORGETOWN UNIVERSITY HOSPITAL

More information

Biological Therapies for Cancer: Questions and Answers

Biological Therapies for Cancer: Questions and Answers Biological Therapies for Cancer: Questions and Answers Key Points Biological therapies use the body s immune system to fight cancer or to lessen the side effects that may be caused by some cancer treatments

More information

Biomarkers: An approach to targeting SMARCB1-deficient sarcomas

Biomarkers: An approach to targeting SMARCB1-deficient sarcomas Biomarkers: An approach to targeting SMARCB1-deficient sarcomas Description The basis for dual targeting SMARCB1-deficient sarcomas with inhibitors towards PDGFRalpha and FGFR1. Key publications Wong et

More information

Trial no. Status Phase Treatment Pre-conditioning Primary endpoints Secondary endpoints Diagnosis Sponsor

Trial no. Status Phase Treatment Pre-conditioning Primary endpoints Secondary endpoints Diagnosis Sponsor Supplemental table 1. Overview of recent clinical phase I and II trials assessing the safety and efficacy of TCR-modified T cells in cancer patients as registered at clinicaltrials.gov by September 1,

More information

Posters and Presentations

Posters and Presentations Posters and Presentations June 2017: American Society of Clinical Oncology (ASCO) Annual - Preliminary Correlative Analysis of PD-L1 expression from the SUNRISE Study. View April 2017: American Association

More information

Immune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment

Immune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment Immune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment 1 Introductions Peter Langecker, MD, PhD Executive Medical Director, Global Oncology Clinipace Worldwide Mark Shapiro Vice President

More information

1 st Annual Treatment-Related Adverse Events Symposium: FOCUS ON MANAGEMENT. Friday, October 27, Zuckerman Research Center, New York City

1 st Annual Treatment-Related Adverse Events Symposium: FOCUS ON MANAGEMENT. Friday, October 27, Zuckerman Research Center, New York City 1 st Annual Treatment-Related Adverse Events Symposium: FOCUS ON MANAGEMENT Friday, October 27, 2017 Zuckerman Research Center, New York City 1 st Annual Treatment-Related Adverse Events Symposium: FOCUS

More information

BIOLOGY OF CANCER. Definition: Cancer. Why is it Important to Understand the Biology of Cancer? Regulation of the Cell Cycle 2/13/2015

BIOLOGY OF CANCER. Definition: Cancer. Why is it Important to Understand the Biology of Cancer? Regulation of the Cell Cycle 2/13/2015 BIOLOGY OF CANCER Why is it Important to Understand the Biology of Cancer? Cynthia Smith, RN, BA, MSN, AOCN Oncology Clinical Nurse Specialist Harrison Medical Center Definition: Cancer Regulation of the

More information

MicroRNA expression profiling and functional analysis in prostate cancer. Marco Folini s.c. Ricerca Traslazionale DOSL

MicroRNA expression profiling and functional analysis in prostate cancer. Marco Folini s.c. Ricerca Traslazionale DOSL MicroRNA expression profiling and functional analysis in prostate cancer Marco Folini s.c. Ricerca Traslazionale DOSL What are micrornas? For almost three decades, the alteration of protein-coding genes

More information

BMT Winter Workshop. 3:05-6:20 PM Workshop - 18 speakers. (Break: 4:35PM)

BMT Winter Workshop. 3:05-6:20 PM Workshop - 18 speakers. (Break: 4:35PM) BMT Winter Workshop Friday, December 8 th, 2017 The Carter Center, Atlanta, GA Workshop Focus: 1. Conditioning Relapse 2. CART 3. Biomarkers & GvHD 4. Microbiota Agenda: 2:00 2:30 PM Speakers Arrive to

More information

Pancreatic intraepithelial

Pancreatic intraepithelial Pancreatic intraepithelial neoplasia (PanIN) Markéta Hermanová St. Anne s University Hospital Brno Faculty of Medicine, Masaryk University Precursor lesions of invasive pancreatic cancer Pancreatic intraepithelial

More information

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated

More information

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated

More information

oncogenes-and- tumour-suppressor-genes)

oncogenes-and- tumour-suppressor-genes) Special topics in tumor biochemistry oncogenes-and- tumour-suppressor-genes) Speaker: Prof. Jiunn-Jye Chuu E-Mail: jjchuu@mail.stust.edu.tw Genetic Basis of Cancer Cancer-causing mutations Disease of aging

More information

Progress Update June 2017 Lay Summary Funding: $6,000,000 Grant Funded: July 2015 Dream Team Members Dream Team Leader:

Progress Update June 2017 Lay Summary Funding: $6,000,000 Grant Funded: July 2015 Dream Team Members Dream Team Leader: SU2C -Ovarian Cancer Research Fund Alliance-National Ovarian Cancer Coalition Dream Team Translational Research Grant: DNA Repair Therapies for Ovarian Cancer AND SU2C Catalyst Merck-Supported Supplemental

More information

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar Link full download:https://getbooksolutions.com/download/test-bank-for-robbinsand-cotran-pathologic-basis-of-disease-9th-edition-by-kumar Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th

More information

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar Link full download: http://testbankair.com/download/test-bank-for-robbins-cotran-pathologic-basis-of-disease-9th-edition-bykumar-abbas-and-aster Test Bank for Robbins and Cotran Pathologic Basis of Disease

More information

Peter P. Yu (President of American Society of Clinical Oncology, ASCO) Collaboration between ASCO and JSCO: Future Perspective

Peter P. Yu (President of American Society of Clinical Oncology, ASCO) Collaboration between ASCO and JSCO: Future Perspective 第 53 回日本癌治療学会学術集会 ASCO, ESMO, ECCO からの招聘演者と講演予定 Peter P. Yu (President of American Society of Clinical Oncology, ASCO) Collaboration between ASCO and JSCO: Future Perspective Ralf A. Stahel (President

More information

number Done by Corrected by Doctor Maha Shomaf

number Done by Corrected by Doctor Maha Shomaf number 19 Done by Waseem Abo-Obeida Corrected by Abdullah Zreiqat Doctor Maha Shomaf Carcinogenesis: the molecular basis of cancer. Non-lethal genetic damage lies at the heart of carcinogenesis and leads

More information

Cancer genetics

Cancer genetics Cancer genetics General information about tumorogenesis. Cancer induced by viruses. The role of somatic mutations in cancer production. Oncogenes and Tumor Suppressor Genes (TSG). Hereditary cancer. 1

More information

2 Diagnosis and Staging of Cancer 2.1 Pathophysiology of cancer 2.2 Classification and staging 2.3 Diagnostic measures for specific cancer types

2 Diagnosis and Staging of Cancer 2.1 Pathophysiology of cancer 2.2 Classification and staging 2.3 Diagnostic measures for specific cancer types Oncology Nursing Sub-Specialty Module Reference: Gobel B. M., Triest-Robertson S. & Vogel W.H. (Eds). (205). Advanced Oncology Nursing Certificate Review and Resources Manual. Pittsburgh: Oncology Nursing

More information

American Cancer Society, Inc. Extramural Grants

American Cancer Society, Inc. Extramural Grants Page: 1 Doctoral Degree Scholarship in Cancer Nursing (DSCN) DSCN-16-064-01 Mann, Tara K., BSN MENTOR: Bailey, Donald (Chip) E., PhD, RN, FAAN Investigating Cognitive, Affective/Sleep Symptoms in Interleukin-2

More information

1.5. Research Areas Treatment Selection

1.5. Research Areas Treatment Selection 1.5. Research Areas Cancer biomarker research embraces many areas of study, including tumorigenesis, metastasis, clinical trial and surrogate endpoints, cell isolation, target identification, drug resistance,

More information

Starr Cancer Consortium Retreat Cold Spring Harbor Laboratory, May 1-2, 2017 Monday, May 1, 2017

Starr Cancer Consortium Retreat Cold Spring Harbor Laboratory, May 1-2, 2017 Monday, May 1, 2017 Starr Cancer Consortium Retreat Cold Spring Harbor Laboratory, May -, 07 Monday, May, 07 9:00 :00 am Attendee Arrival and Check In (Grace Auditorium Lobby) :00 am Welcome and Opening Remarks Bruce Stillman

More information

PLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, Steamboat Springs, Colorado. January 12-15, 2018

PLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, Steamboat Springs, Colorado. January 12-15, 2018 PLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, 2018 16 th Oncology Update: Advances and Controversies Steamboat Springs, Colorado January 12-15, 2018 Friday, January 12, 2018 Registration:

More information

IMMUNOTHERAPY FOR CANCER A NEW HORIZON. Ekaterini Boleti MD, PhD, FRCP Consultant in Medical Oncology Royal Free London NHS Foundation Trust

IMMUNOTHERAPY FOR CANCER A NEW HORIZON. Ekaterini Boleti MD, PhD, FRCP Consultant in Medical Oncology Royal Free London NHS Foundation Trust IMMUNOTHERAPY FOR CANCER A NEW HORIZON Ekaterini Boleti MD, PhD, FRCP Consultant in Medical Oncology Royal Free London NHS Foundation Trust ASCO Names Advance of the Year: Cancer Immunotherapy No recent

More information

Tumor suppressor genes D R. S H O S S E I N I - A S L

Tumor suppressor genes D R. S H O S S E I N I - A S L Tumor suppressor genes 1 D R. S H O S S E I N I - A S L What is a Tumor Suppressor Gene? 2 A tumor suppressor gene is a type of cancer gene that is created by loss-of function mutations. In contrast to

More information

Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber

Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber jweber@dom.wustl.edu Oncogenes & Cancer DNA Tumor Viruses Simian Virus 40 p300 prb p53 Large T Antigen Human Adenovirus p300 E1A

More information

Early Embryonic Development

Early Embryonic Development Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors 2. Receptors 3. Regulatory proteins Maternal

More information

BASIC MECHANISM OF TUMOR IMMUNE SUPPRESSION

BASIC MECHANISM OF TUMOR IMMUNE SUPPRESSION BASIC MECHANISM OF TUMOR IMMUNE SUPPRESSION Zihai Li, M.D., Ph.D. Leader, Cancer Immunology Program Hollings Cancer Center Medical University of South Carolina (MUSC) DISCLOSURE GOALS Understand that immune

More information

Radiation Carcinogenesis

Radiation Carcinogenesis Radiation Carcinogenesis November 11, 2014 Dhyan Chandra, Ph.D. Pharmacology and Therapeutics Roswell Park Cancer Institute Email: dhyan.chandra@roswellpark.org Overview - History of radiation and radiation-induced

More information

Advances in Brain Tumor Research: Leveraging BIG data for BIG discoveries

Advances in Brain Tumor Research: Leveraging BIG data for BIG discoveries Advances in Brain Tumor Research: Leveraging BIG data for BIG discoveries Jill Barnholtz-Sloan, PhD Associate Professor & Associate Director for Bioinformatics and Translational Informatics jsb42@case.edu

More information

The Advent of Immunotherapy in Cancer Therapy

The Advent of Immunotherapy in Cancer Therapy The Memorial Hospital Alumni Society Presents The Advent of Immunotherapy in Cancer Therapy October 17-18, 2013 Rockefeller Research Laboratories 430 East 67th Street, New York, NY 10065 WT1 The Advent

More information

Introduction: Overview of Current Status of Lung Cancer Predictive Biomarkers

Introduction: Overview of Current Status of Lung Cancer Predictive Biomarkers Introduction: Overview of Current Status of Lung Cancer Predictive Biomarkers Program 7:15 7:40 Translocations as predictive biomarkers in lung cancer: Overview Mari Mino Kenudson, MD 7:40 8:05 Translocation

More information

BL-8040: BEST-IN-CLASS CXCR4 ANTAGONIST FOR TREATMENT OF ONCOLOGICAL MALIGNANCIES. Overview and Mechanism of Action Dr.

BL-8040: BEST-IN-CLASS CXCR4 ANTAGONIST FOR TREATMENT OF ONCOLOGICAL MALIGNANCIES. Overview and Mechanism of Action Dr. BL-8040: BEST-IN-CLASS CXCR4 ANTAGONIST FOR TREATMENT OF ONCOLOGICAL MALIGNANCIES Overview and Mechanism of Action Dr. Leah Klapper, CSO 88 BL-8040: Novel CXCR4 Antagonist For Hematological Cancers Indications:

More information

Corporate Medical Policy. Policy Effective February 23, 2018

Corporate Medical Policy. Policy Effective February 23, 2018 Corporate Medical Policy Genetic Testing for FLT3, NPM1 and CEBPA Mutations in Acute File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_flt3_npm1_and_cebpa_mutations_in_acute_myeloid_leukemia

More information

Supplemental Table 1.1: Prostate cancer prognostic tools

Supplemental Table 1.1: Prostate cancer prognostic tools Supplemental Table 1.1: Prostate cancer prognostic tools Features ANN^ BioChemical Capra^ CSQS EBRT Han Outcomes Cancer Specific - - +* + - - Non-Cancer Specific - - - + - - DFS/PFS +* +* +* - +* +* Clinical

More information

Chapt 15: Molecular Genetics of Cell Cycle and Cancer

Chapt 15: Molecular Genetics of Cell Cycle and Cancer Chapt 15: Molecular Genetics of Cell Cycle and Cancer Student Learning Outcomes: Describe the cell cycle: steps taken by a cell to duplicate itself = cell division; Interphase (G1, S and G2), Mitosis.

More information

RUNX1 and FPD/AML Translational Research. The Leukemia and Lymphoma Society / Babich Family Foundation Partnership. September 2016

RUNX1 and FPD/AML Translational Research. The Leukemia and Lymphoma Society / Babich Family Foundation Partnership. September 2016 www.lls.org www.runx1.com RUNX1 and FPD/AML Translational Research The Leukemia and Lymphoma Society / Babich Family Foundation Partnership September 2016 Prepared by L. Greenberger, PhD Chief Scientific

More information

Neuroendocrine Tumors: Just the Basics. George Fisher, MD PhD

Neuroendocrine Tumors: Just the Basics. George Fisher, MD PhD Neuroendocrine Tumors: Just the Basics George Fisher, MD PhD Topics that we will not discuss Some types of lung cancer: Small cell neuroendocrine lung cancer Large cell neuroendocrine lung cancer Some

More information

CANCER 1.7 M 609,000 26% 15.5 M 73% JUST THE FACTS. More Than 1,100 Cancer Treatments in Clinical Testing Offer Hope to Patients

CANCER 1.7 M 609,000 26% 15.5 M 73% JUST THE FACTS. More Than 1,100 Cancer Treatments in Clinical Testing Offer Hope to Patients CANCER MEDICINES IN DEVELOPMENT 2018 REPORT JUST THE FACTS MORE THAN 1.7 M ESTIMATED NEW CASES OF CANCER IN 2018 IN THE UNITED STATES MORE THAN 609,000 U.S. CANCER DEATHS ARE EXPECTED IN 2018 SINCE PEAKING

More information

Steamboat Springs, Colorado. January 15-18, 2016

Steamboat Springs, Colorado. January 15-18, 2016 Friday, January 15, 2016 Registration: Begins at 2:00 pm Plenary Session: 4:00 pm - 6:00 pm 14 th Oncology Update: Advances and Controversies Steamboat Springs, Colorado January 15-18, 2016 Current Status

More information

NATIONAL CORPORATE MEDICAL ASSOCIATES: CANCER TREATMENT UPDATE 2016

NATIONAL CORPORATE MEDICAL ASSOCIATES: CANCER TREATMENT UPDATE 2016 33rd Annual Meeting NATIONAL CORPORATE MEDICAL ASSOCIATES: CANCER TREATMENT UPDATE 2016 Thursday-Friday, June 16-17, 2016 Conference Location: MEMORIAL SLOAN KETTERING CANCER CENTER Rockefeller Research

More information

One Day BMT Course by Thai Society of Hematology. Management of Graft Failure and Relapsed Diseases

One Day BMT Course by Thai Society of Hematology. Management of Graft Failure and Relapsed Diseases One Day BMT Course by Thai Society of Hematology Management of Graft Failure and Relapsed Diseases Piya Rujkijyanont, MD Division of Hematology-Oncology Department of Pediatrics Phramongkutklao Hospital

More information

Tumor responses (patients responding/ patients treated)

Tumor responses (patients responding/ patients treated) Table 1. ACT clinical trial tumor responses and toxicities. a Target antigen Cancer(s) Receptor type Tumor responses (patients responding/ patients treated) Immune-mediated toxicities (patients experiencing

More information

A View to the Future: The Development of Targeted Therapy for Melanoma. Michael Davies, M.D., Ph.D.

A View to the Future: The Development of Targeted Therapy for Melanoma. Michael Davies, M.D., Ph.D. A View to the Future: Science to Survivorship Symposium September 26, 2009 The Development of Targeted Therapy for Melanoma Michael Davies, M.D., Ph.D. Assistant Professor, Melanoma Medical Oncology How

More information

DIVISION OF NEPHROLOGY

DIVISION OF NEPHROLOGY The Division s funding from the NIH has increased from $3.7 Million in 2001 to over $11 Million in 2006. DIVISION OF NEPHROLOGY DR. BARBARA MURPHY was voted President-Elect of the American Society of Transplantation

More information

Action to Cure Kidney Cancer Campaign to Fund Kidney Cancer Research

Action to Cure Kidney Cancer Campaign to Fund Kidney Cancer Research Action to Cure Kidney Cancer 2016 Campaign to Fund Kidney Cancer Research Kidney Cancer Facts 9 th most common cancer in the U.S. Until recently, 3 rd highest rate of increasing incidence of all cancers

More information

Precision oncology through responses and resistance to anti-cancer therapies

Precision oncology through responses and resistance to anti-cancer therapies Precision oncology through responses and resistance to anti-cancer therapies Barry S. Taylor, Ph.D. Departments of Epidemiology/Biostatistics Medicine/Hematology-Oncology Helen Diller Family Comprehensive

More information

The Cancer Genome Atlas & International Cancer Genome Consortium

The Cancer Genome Atlas & International Cancer Genome Consortium The Cancer Genome Atlas & International Cancer Genome Consortium Session 3 Dr Jason Wong Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 31 st July 2014 1

More information

Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser

Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser Melissa S. Cline 1*, Brian Craft 1, Teresa Swatloski 1, Mary Goldman 1, Singer Ma 1, David Haussler 1, Jingchun Zhu 1 1 Center for Biomolecular

More information

Oncology 101. Cancer Basics

Oncology 101. Cancer Basics Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases

More information

Osamu Tetsu, MD, PhD Associate Professor Department of Otolaryngology-Head and Neck Surgery School of Medicine, University of California, San

Osamu Tetsu, MD, PhD Associate Professor Department of Otolaryngology-Head and Neck Surgery School of Medicine, University of California, San Osamu Tetsu, MD, PhD Associate Professor Department of Otolaryngology-Head and Neck Surgery School of Medicine, University of California, San Francisco Lung Cancer Classification Pathological Classification

More information

What causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite)

What causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite) Oncogenes What causes cancer? Chemical factors (carcinogens) Physical factors (radiation, ionization) Biological factors (virus, bacteria, parasite) DNA Mutation or damage Oncogenes Tumor suppressor genes

More information

BMT Winter Workshop. Agenda: 2:00-3:00 PM Meet and Greet. Friday, November 30 th, The NAT, San Diego, CA

BMT Winter Workshop. Agenda: 2:00-3:00 PM Meet and Greet. Friday, November 30 th, The NAT, San Diego, CA BMT Winter Workshop Friday, November 30 th, 2018 The NAT, San Diego, CA Workshop Focus: Section 1. Allogeneic Stem Cell Transplantation and GVHD Section 2. Novel Approaches in Stem Cell Transplantation

More information

Genomic Medicine: What every pathologist needs to know

Genomic Medicine: What every pathologist needs to know Genomic Medicine: What every pathologist needs to know Stephen P. Ethier, Ph.D. Professor, Department of Pathology and Laboratory Medicine, MUSC Director, MUSC Center for Genomic Medicine Genomics and

More information

Contents. Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX

Contents. Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX Contents Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX 1 General Aspects of Signal Transduction and Cancer Therapy 1 1.1 General Principles of Signal Transduction

More information

Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC October 19-21, 2016

Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC October 19-21, 2016 Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC 20037 October 19-21, 2016 Wednesday, October 19, 2016 7:30 8:30 AM Registration

More information

DEPARTMENT OF ONCOLOGY ELECTIVE

DEPARTMENT OF ONCOLOGY ELECTIVE DEPARTMENT OF ONCOLOGY ELECTIVE 2015-2016 www.uwo.ca/oncology Oncology Elective Program Administrator: Ms. Kimberly Trudgeon Room A4-901C (Admin) LHSC London Regional Cancer Centre (Victoria Campus) Phone:

More information

Leukemia Research Foundation Scientific Research Grant Recipients

Leukemia Research Foundation Scientific Research Grant Recipients Page 1 of 5 NEW INVESTIGATOR AWARDS Richard Dahl, Ph.D. University of New Mexico $75,000.00 - Ets and Gfi1 family interactions in T cell development T and B cells comprise the adaptive arm of the vertebrate

More information

Antibody-Drug Conjugates in Glioblastoma Multiforme: Finding Ways Forward

Antibody-Drug Conjugates in Glioblastoma Multiforme: Finding Ways Forward Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples. Major Principles:

1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples. Major Principles: Carcinogenesis 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples Carcinogenesis Major Principles: 1. Nonlethal genetic damage is central to

More information

Off-Label Treatments. Clinical Trials for Recurrent GBM UCSF Radiation Oncology Course: Management of Recurrent Disease. Outline

Off-Label Treatments. Clinical Trials for Recurrent GBM UCSF Radiation Oncology Course: Management of Recurrent Disease. Outline Off-Label Treatments Clinical Trials for Recurrent GBM UCSF Radiation Oncology Course: Management of Recurrent Disease Jennifer Clarke, MD, MPH Assistant Professor Division of Neuro-Oncology Depts of Neurological

More information

Index. neurosurgery.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. neurosurgery.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A A Complimentary Trial of an Immunotherapy Vaccine Against Tumor-specific EGFRvIII (ACTIVATE), 90 91 Active immunotherapy, 5 8, 96. See

More information

Leukemia Research Foundation Scientific Research Grant Recipients

Leukemia Research Foundation Scientific Research Grant Recipients Page 1 of 6 NEW INVESTIGATOR AWARDS Ioannis Aifantis, PhD The University Of Chicago, Chicago, IL $75,000 - Cooperation of Notch and pre-tcr Signaling in the Induction of T Cell Leukemia The main focus

More information